tiprankstipranks
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market

Aptevo Therapeutics (APVO) Income Statement

Compare
488 Followers

Aptevo Therapeutics Income Statement

Last quarter (Q3 2024), Aptevo Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aptevo Therapeutics's net income was $-5.10M. See Aptevo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 3.11M$ 12.29M$ 4.31M$ 32.42M
Gross Profit
$ -567.00K$ 2.21M$ -6.70M$ -13.54M$ 12.50M
Operating Expenses
$ 28.88M$ 31.75M$ 33.69M$ 31.80M$ 40.96M
Depreciation and Amortization
$ 567.00K$ 901.00K$ 1.14M$ 1.41M$ 2.23M
EBITDA
$ -28.31M$ -27.74M$ -20.26M$ -26.09M$ -39.53M
Operating Income
$ -28.88M$ -28.64M$ -21.40M$ -27.49M$ -40.96M
Other Income/Expenses
$ 10.23M$ 35.66M$ -8.01M$ -3.43M$ -2.10M
Pretax Income
$ -18.65M$ 7.01M$ -29.41M$ -30.92M$ -43.06M
Net Income
$ -17.41M$ 42.67M$ -27.31M$ -18.45M$ -40.45M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.32K$ 366.71$ -256.35$ -239.38$ -610.11
Diluted EPS
$ -2.32K$ 367.92$ -256.35$ -239.38$ -610.11
Weighted Average Shares Outstanding
- 116.36K 106.54K 77.07K 66.30K
Weighted Average Shares Outstanding (Diluted)
- 115.97K 106.54K 77.07K 66.30K
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis